Continuous, reliable and real-time assessment of major determinants of cardiovascular function in preterm and term neonates has long been an elusive aim in neonatal medicine. Accordingly, aside from continuous assessment of heart rate, blood pressure and arterial oxygen saturation, bedside monitoring of major determinants of cardiovascular function of significant clinical relevance such as cardiac output, systemic vascular resistance, organ blood flow distribution and tissue oxygen delivery and coupling has only recently become available. Without obtaining reliable information on the changes in and interactions among these parameters in the neonatal patient population during postnatal transition and later in the neonatal period, development of effective and less harmful treatment approaches to cardiovascular compromise is not possible. This paper briefly reviews the recent advances in our understanding of developmental cardiovascular physiology and discusses the methods of bedside assessment of cardiovascular function in general and organ perfusion, tissue oxygen delivery and brain function in particular in preterm and term neonates. The importance of real-time data collection and the need for meticulous validation of the methods recently introduced in the assessment of neonatal cardiovascular function such as echocardiography, electrical impedance cardiometry, near infrared spectroscopy, visible light and laser-Doppler technology are emphasized. A clear understanding of the accuracy, feasibility, reliability and limitations of these methods through thorough validation will result in the most appropriate usage of these methods in clinical research and patient care.
Introduction
Maintenance of normal cardiovascular function is a complex process regulated by the autonomic central and peripheral nervous system, endocrine and paracrine regulatory mechanisms, the cardiovascular system and renal function. 1 Preservation of hemodynamic homeostasis is especially challenging during the complex process of transition to extrauterine life in very preterm neonates 2 and in neonates born with underlying pathological conditions such as complex congenital heart disease; any condition associated with pulmonary parenchymal and vascular hypoplasia or impaired cardiovascular function such as seen in neonates with infection or asphyxia. 3 Abnormal cardiovascular function during postnatal transition or later in the neonatal period is of clinical significant relevance as it is associated with potentially severe morbidity and mortality in the affected patient population. [4] [5] [6] [7] [8] [9] [10] [11] To improve our understanding of developmental cardiovascular physiology and follow the hemodynamic response to treatment of neonatal cardiovascular compromise, attempts have long been made to monitor cardiovascular function of preterm and term neonates requiring intensive care. Unfortunately, limitations of our approach to study neonatal hemodynamics and shortcomings of the available technology have severely curtailed our ability to accurately monitor many of the basic components of cardiovascular function. [12] [13] [14] Indeed, when one looks at the requirements a method is expected to fulfill to measure, for instance, cardiac output (CO), it becomes clear why accurate assessment of this crucial cardiovascular parameter has remained an elusive target in neonatal medicine (Table 1) .
In addition, the success of a given treatment modality aimed at managing cardiovascular dysfunction, such as treatment of neonatal hypotension, cannot be solely judged by its short-term effects on hemodynamic function. Rather, both the hemodynamic effects and the impact on clinically relevant long-term outcomes need to be taken into consideration when the safety and effectiveness of a given treatment approach are being assessed. 1, 10, 11, 15 As the latter requirement is very difficult to fulfill and as we have not as yet been able to establish normal values for most basic cardiovascular function in neonates including the gestational-and postnatal-age-dependent normal ranges of blood pressure (BP), treatment of neonatal circulatory compromise has been based on unproven hypotheses, personal beliefs and experience rather than evidence. As experience in medicine has been often described as 'an ability to make a mistake repeatedly with increasing confidence', it is no wonder why we have not made significant advances in this area of neonatal medicine.
Therefore, to develop appropriate treatment strategies, we first must gain a better understanding of the physiology and pathophysiology of hemodynamic compromise in the human neonate. Data from animal experiments are useful and important, 12,16 -19 but cannot replace information obtained in the human neonate. 2, 20 Thus, methods of complex, continuous, real time and, if possible, non-invasive assessment of the different aspects of cardiovascular function need to be developed first so that essential information on developmental cardiovascular physiology can reliably be obtained in the neonatal patient population. Only after having gained a better insight into the intricate hemodynamic processes during postnatal transition and later in the neonatal period will we be able to develop meaningful treatment strategies and test their effects on clinically relevant short-and long-term outcome measures.
Clinical relevance of cardiovascular monitoring in the preterm and term neonate The primary role of the circulation is to ensure adequate delivery of oxygen and nutrients to the cells so that their metabolic demand is met and removal of byproducts of cellular metabolism achieved. These functions are accomplished by maintenance of appropriate perfusion pressure and CO in the systemic and pulmonary circulations. In the systemic circulation, the interaction between CO and systemic vascular resistance (SVR) regulates BP according to the relationship: BP ¼ CO Â SVR. Note that among these three fundamental factors determining basic cardiovascular function, CO and SVR are the independent variables (regulated by the body) and BP is the dependent variable as it is the product of the interaction between the two independent variables (Figure 1 ). Yet, in routine clinical care, we rely primarily on the information obtained from BP monitoring and, at present, cannot routinely assess the changes in CO and/or SVR when hypotension and/or cardiovascular compromise are diagnosed and treated. 1, 21 Therefore, normalization of BP may result in normal or decreased CO if a primary vasopressor (phenylephrine or norepinephrine) or a vasopressor/inotrope (dopamine or epinephrine) is being used. However, as continuous or even intermittent measurements of CO cannot be obtained in most neonatal intensive care settings on a regular basis, the impact of vasopressor or vasopressor/inotrope administration on CO cannot be directly assessed. Similarly, when a lusitrope (milrinone) or an inotrope (dobutamine) is administered in cases where low systemic blood flow because of myocardial dysfunction is suspected in the presence or absence of an elevated SVR, the impact of these treatment approaches on CO cannot be objectively ascertained. Moreover, as maintenance of cardiovascular wellbeing is a dynamic function, these complex interactions can only be assessed at the bedside if, in addition to continuous heart rate, BP and arterial oxygen saturation (SpO 2 ) monitoring, continuous CO monitoring with or without assessment of the SVR could be accomplished. At present, such monitoring system is not available in clinical practice, but may become part of hemodynamic monitoring in the future (see below).
Although the above interactions in themselves are complex, understanding the regulation of tissue oxygen delivery in its entirety requires more than obtaining information on the interactions among BP, CO and SVR. Indeed, one also needs to consider whether or not a normal distribution of blood flow to the organs has been maintained especially when indirect clinical signs of cardiovascular compromise are observed in the presence of a normal BP (Figure 1) . In other words, one needs to be able to diagnose neonatal shock in its early, 'compensated phase' when blood flow and oxygen delivery are maintained to the vital organs (brain, heart and adrenal glands) at the expense of decreased blood flow and oxygen delivery to the rest of the organs (non-vital organs). 2, 22 The vessels of vital organs vasodilate when perfusion pressure decreases (high-priority vasculature), whereas the vessels of non-vital organs respond with vasoconstriction to a decrease in BP (low-priority vasculature). Neuroendocrine compensatory and local vascular mechanisms are responsible for the vasodilatory and vasoconstrictive actions in response to a decrease in perfusion pressure in the vital and non-vital organs, respectively. At present, continuous assessment of vital and non-vital organ mixed venous tissue oxygen saturation can be performed in real time by the use of near infrared spectroscopy (NIRS) and used, with caution, as a surrogate measure of organ blood flow (see below 23, 24 ). Finally, by appropriate adjustments in local tissue perfusion, maintenance of coupling of oxygen demand to oxygen delivery The method is expected to be validated against one of the 'gold standards' of cardiac output measurements be accurate along the entire spectrum of gestational age and birth weight provide continuous measurements in absolute numbers be reliable, practical and non-invasive be easy to apply and interpret and inexpensive so that its widespread use would becomes feasible be useful in neonates with extra-and intra-cardiac shunting (PDA, PFO) during the postnatal transitional period and in neonates with congenital heart disease be continuously recordable along with other measures of physiologic monitoring
Abbreviations: PDA, patent ductus arteriosus; PFO, patent foramen ovale. a None of the presently used methods comes even close to fulfilling these criteria.
is essential for normal organ function and for the preservation of organ integrity. 25, 26 This process is especially important in the developing brain where some evidence suggests that the vessels of the forebrain of the very preterm neonate do not function as 'high-priority' vessels at birth. Thus, in these neonates, the vasculature of the forebrain responds to stress and associated decreases in perfusion pressure by vasoconstriction even as BP remains in the perceived normal range. Therefore, in the forebrain of these neonates at birth, oxygen demand cannot be satisfied by changes in local blood flow, the primary and most efficient mechanism of oxygen demand and delivery coupling. Rather, it is accomplished by secondary mechanisms of oxygen demand-delivery coupling such as increased tissue oxygen extraction and recruitment of more capillaries. 2, 27, 28 It appears, however, that within days after delivery, the assignment of the forebrain vasculature matures to 'high-priority' and thus these vessels will vasodilate in response to decreases in perfusion pressure. It has been speculated that this process may worsen reperfusion injury to the brain during the first postnatal days and contribute to the development of intraventricular hemorrhage in the very preterm infant. 2, 3 The cellular mechanisms of vessel functional priority assignment in vital and non-vital organs are not well understood. 29 Furthermore, if the secondary measures of compensatory mechanisms of oxygen demand and delivery coupling (increased oxygen extraction and capillary recruitment) are exhausted before reperfusion takes place, anaerobic metabolism with inefficient ATP and increased lactate production develop. If the condition is sustained or severe, tissue ischemia/hypoxemia will result in end-organ damage presenting as periventricular leukomalacia or ischemic cortical injury, which, following reperfusion, may again contribute to the development of intraventricular hemorrhage. 29 NIRS and magnetic resonance imaging can by used to monitor some of the mechanisms of oxygen demand and delivery coupling (blood flow and oxygen extraction). Although routine bedside use of magnetic resonance imaging is not yet available, preliminary data on the assessment of local cerebral blood flow and oxygen delivery simultaneously using NIRS and magnetic resonance imaging are now available. 30 Assessment of cardiovascular function, organ perfusion, oxygen delivery and brain function in neonates at the bedside The available methods for the assessment of global cardiovascular function and its components are depicted in Table 2 . These techniques are generally required to fulfill at least the most important and clinically relevant expectations of an 'ideal' cardiovascular monitoring method described in Table 1 . These expectations include that the methods be validated, reliable and accurate along the entire spectrum of gestational age and provide continuous measurements in absolute numbers preferentially in a non-invasive manner. 20 As to the point of accuracy, close and thus, acceptable correlation with the findings of a method already validated and used at the bedside is a requirement. However, as none of the methods used at the bedside and validated is very highly accurate, one should allow for some bias and imprecision as long as the direction of changes in the measured parameter is consistently in agreement between the method being tested and the 'gold standard' used for validation. For instance, validation of impedance electrical cardiometry (IEC) (Aesculon; Cardiotronic; La Jolla, CA, USA) to non-invasively assess beat-to-beat CO is underway using echocardiographic measurements of CO as the method of 'gold standard' in the authors' program. Preliminary data show a good agreement (bias), but a wide variation (precision) between the average left ventricular output measured by echocardiography and IEC. 31 Thus, the clinical utility of IEC in the assessment of CO in neonates will hinge on the findings of ongoing studies looking at the tightness of the agreement in the direction of CO changes between echocardiography and IEC when different treatment modalities are applied in neonates to affect CO (see below).
It is also clear that only the combined use of the techniques capable of monitoring the most important components of cardiovascular function can provide the information required for the timely recognition and appropriate management of neonatal cardiovascular compromise. The system designed and used for hemodynamic monitoring and data collection for clinical research by the authors 32 integrates conventionally used technologies to continuously monitor heart rate, BP, oxygen saturation (SpO 2 ) and transcutaneous CO 2 with novel technologies including impedance IEC for continuous beat-to-beat assessment of CO and some of its determinants such as stroke volume and NIRS (INVOS, Somanetics; Troy, MI, USA) to monitor organ blood flow distribution to a vital organ (brain) and several non-vital organs (kidney, intestine and/or muscle) in neonates. The hemodynamic monitoring tower collects the conventional hemodynamic parameters directly through conventional modules, whereas the NIRS and IEC signals are collected through Vuelink modules (Philips; Boeblingen, Germany). Output of the continuous streams of the measured parameters is performed using the analog output option of the patient monitoring system. An analog-to-digital converter coupled with a data-acquisition system collects the data on a laptop computer. A motion-activated camera with time-stamped digital recording records activities around the patient so that visual information of the patient after the study has been completed can be recalled later during data analysis. This is an important function as it allows differentiating between real hemodynamic events and suspected malfunction of the monitoring devices. Such malfunction may occur with provision of routine clinical care and/or accidental removal or disconnection of monitoring electrodes or cables during the study; events easily identified on the recorded video. Of note is that BP, CO and organ blood flow distribution are being simultaneously monitored by the hemodynamic monitoring system and thus information on pressure-flow relationship can be obtained. However, it must be emphasized that, although studies on validation of IEC have been published in the pediatric patient population, 33 it is an ongoing project in the neonatal patient population with only preliminary data available at present. 31 Therefore, as long as validation is not completed and the limitations of the use of IEC to continuously monitor systemic blood flow in neonates have not been clearly identified, the method cannot be used to perform clinical research or guide treatment in neonates with cardiovascular compromise. In addition, further studies are needed to clearly establish the clinical relevance and utility of the use of NIRS in the neonatal patient population. 24 Finally, a study to evaluate the use of visible light technology (T-Stat; Spectros, Portola Valley, CA, USA) to continuously, noninvasively and indirectly assess changes in SVR is underway.
Whether T-Stat 34 can be used as a surrogate to detect changes in SVR and thus addition of this technology to the hemodynamic monitoring tower could provide clinically relevant information remain to be seen. Figure 2 shows the recording in a 26-week preterm neonate between 6 and 9 h of postnatal life with some but not all of the presently monitored cardiovascular parameters continuously and simultaneously recorded, downloaded and stored for further analysis using the hemodynamic monitoring tower. The recording depicts a desaturation episode (arrow #1) where respiratory rate, SpO 2 , cerebral (rSO 2 -1) and renal (rSO 2 -2) tissue oxygen saturations and systolic, mean and diastolic BP fell around 6 h and 15 min of age followed by a full apneic event. Heart rate barely changed during the episode. BP recovered approximately half an hour after SpO 2 and cerebral and renal tissue oxygen saturations had recovered (arrow #2). It appears that variability in cerebral tissue oxygen saturation decreased at the same time when BP stabilized, whereas renal tissue oxygen saturation having continued to mirror changes in SpO 2 and somewhat in BP, suggesting that cerebral but not renal blood flow autoregulation may have, at least in part, recovered. Finally, heart rate and respiratory rate appear to have decreased and stabilized only after these changes took place (just before 7.5 h of age; arrow #3). Even this example with relatively limited monitoring of the most relevant hemodynamic parameters illustrates the potential utility of simultaneous, realtime monitoring of these parameters for clinical research so that Figure 2 Selected hemodynamic parameters recorded by the monitoring tower in a 26 weeks' gestation extremely preterm neonate during the first day after delivery. Hemodynamic parameters continuously monitored by the hemodynamic monitoring tower in the 26 weeks' gestation, <1-day-old extremely preterm neonate included arterial oxygen saturation (SpO 2 ), heart rate (HR), respiratory rate (RESP), systolic (Sys), diastolic (Dia) and mean (Mean) BP and cerebral (rSO 2 -1) and renal (rSO 2 -2) mixed venous tissue oxygen saturation using near infrared spectroscopy. These parameters are depicted on the y -axis, whereas age after delivery in hours is shown on the x axis.
the interactions among the different cardiorespiratory parameters and the developmentally regulated function of the cardiovascular system can be critically studied. As stated earlier, only after having obtained critical information on developmental neonatal hemodynamics and cardiovascular pathophysiology can we design etiology-targeted treatment modalities and monitor the hemodynamic response to these treatment approaches in cases of neonatal hemodynamic compromise.
Conventional assessment BP, heart rate, SpO 2 . A direct continuous reading from an indwelling arterial line is considered the 'gold standard' of BP measurement in the critically ill neonate. Although BP is also frequently measured non-invasively, its accuracy is less certain especially in cases where severe hypotension develops. In addition, non-invasive assessment of BP is not continuous. For more detailed information on BP measurement in the neonate, the reader is referred to reviews on BP monitoring in the neonate.
35-37
Heart rate is continuously, accurately and routinely monitored in neonates admitted to the NICU. However, as many factors other than those regulating the cardiovascular system affect heart rate, it has a limited role in the diagnosis of circulatory compromise.
Introduction of continuous SpO 2 measurements in neonatology decades ago represented a significant advancement in our ability to assess the status of oxygenation on the arterial side of the circulation. Several methods are available to monitor SpO 2 . As discussion of these methods and their limitations and clinical utility is beyond the scope of this paper, the reader is referred to reviews in the literature available on this topic. 38 Indirect clinical and laboratory signs of cardiovascular function In the absence of non-invasively and continuously monitored and validated measures of systemic blood flow, clinicians have used rather non-specific indirect measures of systemic blood flow and tissue perfusion including urine output, capillary refill time, peripheral-core temperature difference and serum lactate levels. These indirect signs of tissue perfusion have significant limitations, but are the only routinely and widely available measures of systemic blood flow and tissue perfusion in neonatal clinical care at present. Data on their clinical utility is rather limited. As discussion on the clinical use and utility of these clinical and laboratory measures of neonatal cardiovascular function is beyond the scope of this paper, the reader is referred to recent reviews on this topic. 1, 22, 39 Assessment of systemic and organ blood flow and tissue oxygen delivery and consumption Among the available technologies, functional echocardiography has been increasingly used by both neonatologists and pediatric cardiologists to assess CO, myocardial function and organ blood flows in neonates requiring provision of intensive care. 13 Although this non-continuous and non-invasive modality has significant technical limitations as well as limitations associated with its personnel and equipment needs, its use in clinical research has provided extremely valuable novel information on the function of the cardiovascular system especially in preterm neonates during the transitional period. As mentioned earlier, the use of NIRS for the continuous, non-invasive assessment of tissue oxygenation and perhaps organ blood flow distribution appears to be promising for clinical use in neonatology, but more data are needed to establish its clinical relevance and utility to guide treatment. 24 Monitoring of peripheral and mucosal blood flow can be accomplished by the use of laser Doppler, 40 side-stream dark field imaging 41 and visible light (T-Stat 34 ) technologies. Although these devices have only been used for clinical research in neonates by a rather limited group of researchers, the findings of these studies have contributed to a better understanding and appreciation of the complexity of the regulation of cardiovascular function in preterm and term neonates during postnatal transition and beyond.
Functional assessment
In addition to monitoring the most important components of cardiovascular function using the approaches described earlier, a continuous, fairly crude but practical bedside monitoring technique of cerebral electrical activity is now available in the form of amplitude-integrated EEG (aEEG). Although aEEG has significant limitations, 42 it is being increasingly used in neonates especially for the diagnosis of hypoxic-ischemic encephalopathy and for monitoring the changes in brain activity in neonates with hypoxicischemic encephalopathy in response to therapeutic hypothermia. 43 In addition, aEEG has been used in clinical research to study the relationship between the changes in neonatal cardiovascular function and brain activity during postnatal transition and the impact of cardiovascular compromise and its treatment on brain activity. Some of these studies have provided interesting and thought-provoking information on the relationship between BP and CO and cerebral function even in very preterm neonates during the transitional period. 44 Further studies are needed to establish the clinical relevance of these findings using aEEG and the utility of this technology to provide information on clinically relevant long-term outcome measures in these patients.
Data collection requires use of real-time data-acquisition systems The use of complex, multichannel, real-time monitoring towers combined with streamlined data-acquisition systems is the only reasonable approach to obtain meaningful data on neonatal hemodynamics for clinical research. Complex data-acquisition systems have been developed and are commercially available (VitalSync; Somanetics) for use in neonatal medicine. However, rate of data acquisition and storage capacity and compatibility of the data-acquisition system with clinically available monitors and devices are just a few of the many outstanding issues these systems need to improve on before their use in clinical research can become more widespread.
Summary
This paper provided a brief overview of the available hemodynamic monitoring and data-acquisition systems used in neonates. Although significant advances in technology and our understanding of developmental cardiovascular physiology and pathophysiology have taken place over the past two decades, the development of complex monitoring systems capable of continuous, noninvasive, accurate and simultaneous monitoring of the major determinants of cardiovascular function (BP, CO, SVR, organ blood flow distribution and coupling of tissue oxygen delivery to demand) has just begun. In addition, thoughtful, unbiased and critical validation of some of the components of these systems using the 'gold standards' of the parameter assessed by the given monitoring technology must be carried out. Only after appropriate validation of its components can the entire system be used for monitoring the complexity of the interactions among the major determinants of cardiovascular function so that more insight in neonatal hemodynamics can be gained. Once having achieved this goal, we will be able to start designing and testing more appropriate treatment modalities tailored to the pathophysiology of neonatal cardiovascular compromise so that short-and long-term neonatal outcomes of neonates presenting with shock during postnatal transition or later in the neonatal period can be improved.
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